PGEN
Price
$0.69
Change
-$0.02 (-2.82%)
Updated
Dec 13, 04:59 PM (EDT)
75 days until earnings call
PLRX
Price
$13.32
Change
-$0.53 (-3.83%)
Updated
Dec 13, 04:59 PM (EDT)
81 days until earnings call
Ad is loading...

PGEN vs PLRX

Header iconPGEN vs PLRX Comparison
Open Charts PGEN vs PLRXBanner chart's image
Precigen
Price$0.69
Change-$0.02 (-2.82%)
Volume$5.55K
CapitalizationN/A
Pliant Therapeutics
Price$13.32
Change-$0.53 (-3.83%)
Volume$28.4K
CapitalizationN/A
PGEN vs PLRX Comparison Chart
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PGEN vs. PLRX commentary
Dec 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a Hold and PLRX is a Hold.

COMPARISON
Comparison
Dec 14, 2024
Stock price -- (PGEN: $0.68 vs. PLRX: $13.30)
Brand notoriety: PGEN and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 208% vs. PLRX: 66%
Market capitalization -- PGEN: $197.77M vs. PLRX: $809.35M
PGEN [@Biotechnology] is valued at $197.77M. PLRX’s [@Biotechnology] market capitalization is $809.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $489.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both PGEN and PLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 3 TA indicator(s) are bullish while PLRX’s TA Score has 5 bullish TA indicator(s).

  • PGEN’s TA Score: 3 bullish, 5 bearish.
  • PLRX’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than PGEN.

Price Growth

PGEN (@Biotechnology) experienced а -13.04% price change this week, while PLRX (@Biotechnology) price change was -9.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.93%. For the same industry, the average monthly price growth was -4.54%, and the average quarterly price growth was +6.84%.

Reported Earning Dates

PGEN is expected to report earnings on Feb 26, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($809M) has a higher market cap than PGEN($198M). PLRX YTD gains are higher at: -23.523 vs. PGEN (-46.866). PGEN has higher annual earnings (EBITDA): -136.11M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. PGEN (28.6M). PGEN has less debt than PLRX: PGEN (5.75M) vs PLRX (60.2M). PGEN has higher revenues than PLRX: PGEN (3.96M) vs PLRX (0).
PGENPLRXPGEN / PLRX
Capitalization198M809M24%
EBITDA-136.11M-197.04M69%
Gain YTD-46.866-23.523199%
P/E RatioN/AN/A-
Revenue3.96M0-
Total Cash28.6M405M7%
Total Debt5.75M60.2M10%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PGENPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
View a ticker or compare two or three
Ad is loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMMTX16.85-0.05
-0.30%
Russell Inv Emerging Markets M
PGPCX25.87-0.11
-0.42%
George Putnam Balanced C
JETIX14.96-0.10
-0.66%
abrdn Global Equity Impact Instl
HAOSX13.60-0.09
-0.66%
Harbor International Core Institutional
EPGAX22.77-0.16
-0.70%
Fidelity Advisor Equity Growth A

PGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PGEN has been loosely correlated with CRSP. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if PGEN jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGEN
1D Price
Change %
PGEN100%
-5.09%
CRSP - PGEN
55%
Loosely correlated
-4.98%
NTLA - PGEN
53%
Loosely correlated
-3.83%
ARWR - PGEN
52%
Loosely correlated
-2.60%
BEAM - PGEN
51%
Loosely correlated
-2.91%
DNLI - PGEN
51%
Loosely correlated
-1.68%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-2.46%
NTLA - PLRX
53%
Loosely correlated
-3.83%
BEAM - PLRX
51%
Loosely correlated
-2.91%
RCKT - PLRX
51%
Loosely correlated
-5.98%
PRME - PLRX
50%
Loosely correlated
-4.75%
INZY - PLRX
49%
Loosely correlated
+0.68%
More